X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (397) 397
male (294) 294
female (249) 249
electrocardiography (210) 210
index medicus (175) 175
animals (162) 162
atrioventricular block - chemically induced (161) 161
middle aged (161) 161
cardiac & cardiovascular systems (154) 154
aged (131) 131
heart block - chemically induced (128) 128
atrioventricular node - drug effects (126) 126
adult (113) 113
heart rate - drug effects (85) 85
heart conduction system - drug effects (82) 82
pharmacology & pharmacy (79) 79
dogs (75) 75
arrhythmia (67) 67
atrioventricular block (65) 65
electrocardiography - drug effects (60) 60
dose-response relationship, drug (59) 59
torsades de pointes - chemically induced (57) 57
atrioventricular block - physiopathology (56) 56
atrioventricular-block (55) 55
heart block - physiopathology (52) 52
arrhythmias, cardiac - chemically induced (49) 49
heart (48) 48
atrioventricular node - physiopathology (47) 47
bradycardia - chemically induced (47) 47
cardiac pacing, artificial (42) 42
heart - drug effects (42) 42
time factors (40) 40
cardiac arrhythmia (39) 39
electrophysiology (39) 39
heart block (39) 39
anti-arrhythmia agents - adverse effects (38) 38
atrioventricular block - diagnosis (36) 36
torsades de pointes - physiopathology (36) 36
adenosine (35) 35
treatment outcome (35) 35
disease models, animal (34) 34
heart conduction system - physiopathology (34) 34
aged, 80 and over (33) 33
arrhythmias (32) 32
long qt syndrome - chemically induced (32) 32
toxicology (32) 32
bradycardia (31) 31
adolescent (30) 30
anti-arrhythmia agents - pharmacology (30) 30
risk factors (30) 30
analysis (29) 29
cardiovascular (29) 29
arrhythmias, cardiac - physiopathology (28) 28
complete atrioventricular-block (28) 28
atrioventricular node - physiology (27) 27
blood pressure - drug effects (27) 27
pacemaker, artificial (26) 26
cardiology (25) 25
atrioventricular block - therapy (24) 24
heart rate (24) 24
long-qt syndrome (24) 24
medicine & public health (24) 24
medicine, general & internal (24) 24
safety (24) 24
adenosine - administration & dosage (23) 23
adenosine - adverse effects (23) 23
adenosine - pharmacology (23) 23
early afterdepolarizations (23) 23
guinea pigs (23) 23
rabbits (23) 23
tachycardia (23) 23
torsade-de-pointes (23) 23
electrocardiogram (22) 22
tachycardia - chemically induced (22) 22
torsades de pointes (22) 22
torsades-de-pointes (22) 22
action potentials - drug effects (21) 21
atrioventricular node (21) 21
cardiovascular system (21) 21
child (21) 21
conduction (20) 20
follow-up studies (20) 20
long qt syndrome (20) 20
toxicity (20) 20
clinical neurology (19) 19
infusions, intravenous (19) 19
prolongation (19) 19
anesthesia (18) 18
anesthesiology (18) 18
anti-arrhythmia agents - therapeutic use (18) 18
diagnosis, differential (18) 18
heart block - diagnosis (18) 18
pediatrics (18) 18
sinoatrial node - drug effects (18) 18
syncope (18) 18
tachycardia - physiopathology (18) 18
verapamil (18) 18
arrhythmias, cardiac - drug therapy (17) 17
qt interval (17) 17
verapamil - pharmacology (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (488) 488
German (11) 11
French (8) 8
Spanish (5) 5
Hungarian (2) 2
Japanese (2) 2
Polish (2) 2
Chinese (1) 1
Hebrew (1) 1
Italian (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, 8/2013, Volume 10, Issue 4, pp. 500 - 510
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 11/2014, Volume 281, Issue 1, pp. 39 - 47
Journal Article
Cardiovascular Research, ISSN 0008-6363, 01/2013, Volume 97, Issue 1, pp. 23 - 32
Several drugs blocking the rapidly activating potassium (K-r) channel cause malformations (including cardiac defects) and embryonic death in animal teratology... 
Embryo | Long-QT syndrome | Arrhythmia | K-channel | Teratogenicity | DRUG ALMOKALANT | CARDIAC & CARDIOVASCULAR SYSTEMS | MOUSE HEART | CARDIAC-ARRHYTHMIA | HYPOXIA | MICROELECTRODE ARRAYS | DEVELOPMENTAL TOXICITY | SEROTONIN REUPTAKE INHIBITORS | III ANTIARRHYTHMIC AGENT | HEART DEVELOPMENT | POTASSIUM CHANNEL | Heart Defects, Congenital - chemically induced | Teratogens - toxicity | Rats, Wistar | Species Specificity | Humans | KCNQ1 Potassium Channel - metabolism | Ether-A-Go-Go Potassium Channels - metabolism | Long QT Syndrome - chemically induced | Atrioventricular Block - chemically induced | ERG1 Potassium Channel | RNA, Messenger - metabolism | Action Potentials | Heart Defects, Congenital - genetics | Potassium Channels, Voltage-Gated - metabolism | Gene Expression Regulation, Developmental | KCNQ1 Potassium Channel - antagonists & inhibitors | Polymerase Chain Reaction | Electrocardiography | Potassium Channel Blockers - toxicity | Potassium Channels, Voltage-Gated - genetics | Piperidines - toxicity | Rabbits | Atrioventricular Block - metabolism | Cells, Cultured | Rats | Potassium Channels, Voltage-Gated - antagonists & inhibitors | Gestational Age | Rats, Sprague-Dawley | Organogenesis | Ether-A-Go-Go Potassium Channels - antagonists & inhibitors | Long QT Syndrome - metabolism | Patch-Clamp Techniques | Animals | Myocytes, Cardiac - drug effects | Pyridines - toxicity | Myocytes, Cardiac - metabolism | Heart Defects, Congenital - metabolism | Kinetics | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
Fundamental & Clinical Pharmacology, ISSN 0767-3981, 08/2017, Volume 31, Issue 4, pp. 392 - 402
Cardiac arrhythmias and ECG abnormalities including bradycardia, prolongation of the QT interval, and atrioventricular (AV) conduction blocks have been... 
ECG | calcium currents | cardiac arrhythmias | action potentials | fingolimod | CARDIAC-FUNCTION | ORAL FINGOLIMOD | PIG ATRIAL MYOCYTES | HEALTHY-SUBJECTS | POTASSIUM CHANNELS | VENTRICULAR MYOCYTES | LYMPHOCYTE EGRESS | SPHINGOSINE 1-PHOSPHATE | PHARMACOLOGY & PHARMACY | RENAL-TRANSPLANT PATIENTS | PLACEBO-CONTROLLED TRIAL | Fingolimod Hydrochloride - pharmacology | Heart - physiology | Immunosuppressive Agents - therapeutic use | Calcium Channel Blockers - therapeutic use | Male | Atrioventricular Block - chemically induced | Heart Rate - drug effects | Multiple Sclerosis - physiopathology | Heart Conduction System - physiology | Heart Rate - physiology | Immunosuppressive Agents - pharmacology | Fingolimod Hydrochloride - therapeutic use | Fingolimod Hydrochloride - toxicity | Atrioventricular Block - physiopathology | Guinea Pigs | Bradycardia - physiopathology | Calcium Channels, L-Type - physiology | Heart Conduction System - drug effects | Calcium Channel Blockers - pharmacology | Immunosuppressive Agents - toxicity | Calcium Channel Blockers - toxicity | Bradycardia - chemically induced | Animals | Heart - drug effects | Multiple Sclerosis - drug therapy | Phosphates | Heart | Bradycardia | Calcium channels | Multiple sclerosis | Electrocardiogram | Electrocardiography | EKG | Pigs | Cardiac arrhythmia | Conduction | Surgical implants | Calcium | Abnormalities | Calcium channels (voltage-gated) | Electrophysiology | Action potential | Exposure | Experiments | Nerve conduction | Perfusion | Phosphate | Calcium channels (L-type) | Heart diseases | In vitro methods and tests | Prolongation
Journal Article